Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Paired brain and wrist nerve stimulation to boost hand motor plasticity in the cervical spinal cord

Official title: Paired Non-invasive Stimulation of Hand Motor Cortex and Median Nerve to Induce Plasticity in the Cervical Spinal Cord

Run by Columbia University · NCT07539025 · Data updated 2026-11-12

This research will test if pairing weak brain stimulation with median nerve stimulation can increase spinal-cord-based plasticity and strengthen hand motor responses in healthy adults.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment20 (estimated)
SponsorColumbia University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMay 9, 2026
Main results expectedDecember 2028
Study endsJune 2029
Registry record updatedMay 22, 2026
Trial IDNCT07539025 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are typically developing adults who can give informed consent, have no central or peripheral neurological disease or tested-arm musculoskeletal injury, can maintain usual caffeine and exercise levels, and are willing to attend up to four sessions.

Probably not a fit

People with a personal or family history of seizures, current use of medications that lower seizure threshold, implanted stimulators or pacemakers, or existing neurological or tested-arm injuries are not eligible and are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This confirmatory experimental study applies the SCAP-Nerve protocol, pairing sub‑threshold hand motor cortical stimulation with median nerve pulses timed to converge in the cervical spinal cord. Typically developing adult volunteers will undergo up to four sessions measuring physiological outcomes such as motor-evoked potentials and behavioral measures of upper-limb motor responses. Participants with seizure risk, implanted devices, or local musculoskeletal injury are excluded for safety. The goal is to confirm prior lab findings that cervical spinal cord convergence produces larger motor responses than convergence in the motor cortex.

Why it matters

Potential benefit: If successful, the approach could provide a noninvasive way to strengthen hand motor pathways and inform therapies to improve arm and hand function after spinal cord injury or other motor disorders.

How similar studies have gone: Prior paired associative stimulation work, including published results from the Carmel laboratory, has shown promise and suggests that timing convergence in the cervical spinal cord can produce larger upper-limb motor responses than cortical convergence, but this study is a confirmatory test in healthy adults.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Willingness to participate in up to 4 sessions
* Maintenance of caffeine and exercise levels at time of sessions
* Ability to provide informed consent
* No known central or peripheral neurological disease or injury
* No known musculoskeletal injury of the tested arm or hand

Exclusion Criteria:

* Personal or family history of seizures
* Use of medications that lower seizure threshold
* History of implanted equipment including stimulators/pacemakers

Where it's running

  • Columbia University Irving Medical Center
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.